We are live on ! Find out more
PC

Paulson & Co Portfolio holdings

AUM $3.11B
1-Year Est. Return 94.93%
This Fund
S&P 500
This Quarter Est. Return
+14.51%
1 Year Est. Return
+94.93%
3 Year Est. Return
+233.32%
5 Year Est. Return
+258.51%
10 Year Est. Return
+934.97%
AUM
$3.26B
AUM Growth
+$293M
Cap. Flow
-$91.7M
Cap. Flow %
-2.81%
Top 10 Hldgs %
100%
Holding
11
New
1
Increased
2
Reduced
1
Closed
2

Top Buys

Rank Stock Value
1
SOLS
Solstice Advanced Materials
SOLS
+$65.7M
2
BHC icon
Bausch Health
BHC
+$16.4M
3
THRY icon
Thryv Holdings
THRY
+$531K

Top Sells

Rank Stock Value
1
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$102M
2
HON icon
Honeywell
HON
+$42.1M
3
TMQ
Trilogy Metals
TMQ
+$30.1M

Sector Composition

Rank Sector Weight
1 Healthcare 46.09%
2 Materials 41.95%
3 Financials 11.16%
4 Technology 0.81%
5 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDGL icon
1
Madrigal Pharmaceuticals
MDGL
$12.4B
$994M 30.48%
1,707,522
-200,001
-10% -$102M
PPTA
2
Perpetua Resources
PPTA
$2.13B
$783M 24.01%
32,347,299
BHC icon
3
Bausch Health
BHC
$1.75B
$509M 15.61%
73,255,869
+2,500,000
+4% +$16.4M
AAMI
4
Acadian Asset Management
AAMI
$2.93B
$364M 11.16%
7,743,282
NG icon
5
NovaGold Resources
NG
$2.29B
$254M 7.78%
27,238,061
AEM icon
6
Agnico Eagle Mines
AEM
$68.2B
$133M 4.07%
783,561
THM
7
International Tower Hill Mines
THM
$523M
$131M 4.01%
70,239,388
SOLS
8
Solstice Advanced Materials
SOLS
$8.97B
$67.8M 2.08%
+1,395,787
New +$65.7M
THRY icon
9
Thryv Holdings
THRY
$171M
$26.3M 0.81%
4,347,070
+67,070
+2% +$531K
HON icon
10
Honeywell
HON
$71.7B
-212,200
Closed -$42.1M
TMQ
11
Trilogy Metals
TMQ
$515M
-14,326,996
Closed -$30.1M

Similar funds

Paulson & Co's Q4 2025 Portfolio in Review

As of Q4 2025, Paulson & Co held 11 positions worth $3.26B, up 9.9% from $2.97B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Paulson & Co's Q4 2025 filing shows 1 new, 2 increased, 1 reduced and 2 closed positions. Its largest new stake was Solstice Advanced Materials: 1,395,787 shares worth $67.8M. The largest sale was Madrigal Pharmaceuticals, an estimated $102M.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 45% a quarter earlier, followed by Materials and Financials.

  • Paulson & Co's largest Q4 2025 buy was Solstice Advanced Materials: 1,395,787 shares worth $67.8M.
  • Paulson & Co added most to Bausch Health in Q4 2025, an estimated $16.4M increase.
  • Paulson & Co's biggest Q4 2025 reduction was Madrigal Pharmaceuticals, cutting an estimated $102M.
  • Paulson & Co fully exited Honeywell in Q4 2025, selling an estimated $42.1M.
  • Paulson & Co's ten largest holdings make up 100% of its $3.26B portfolio in Q4 2025.
  • Paulson & Co opened 1 new position and closed 2 in Q4 2025.
  • Paulson & Co's portfolio value rose 9.9% quarter-over-quarter to $3.26B.

Based on Paulson & Co's 13F filing for Q4 2025, filed 17 Feb 2026.